Celecoxib (Celebrex) (S24E6)

All right, welcome back for another deep dive.
Yeah, always exciting to dig into these. Absolutely.
Especially when it's driven by, you know, what
you guys want to know more about. Exactly. You
asked. And today we're diving into Celecoxib.
better known as Celebrex. We're gonna cover a
lot of ground, starting with kind of its origins,
how it's used, how it's made, that whole regulatory
pathway, the ins and outs. Yeah, all this stuff
you don't really think about when you just see
it on the shelf, right? Exactly. And then of
course we'll look at the bigger picture, how
it all fits in and what kind of impact it's had.
Yeah, I think it'll be interesting to see. I
mean, we don't have like a whole file specifically
on Celebrex itself. Right. But we've got a ton
of info on other pain relievers and anti -inflammatories.
Oh, yeah, for sure. Like aspirin, ibuprofen,
naproxen. Exactly. Diclofenac, acetaminophen,
all those big names. Yeah, yeah. So by looking
at those, we can kind of draw some parallels,
right? Get a better understanding of how Celebrex
kind of came to be and where it fits in. I think
that's a great approach because, I mean, when
you look at the history of these medications,
celicoxib is what's known as a COX inhibitor,
right? And to understand that, you really got
to go back and look at those older NSAIDs, the
non -steroidal anti -inflammatory drugs. Yeah,
I think so. We're talking aspirin, ibuprofen,
Amprox, and the classics. Right, right. But there's
a big thing with those, and it pops up in a lot
of our sources, like the stuff on diclofenac,
acetaminophen, all of them, they can cause some
problems in your gut. Yeah, the GI issues. Exactly,
the GI risks. And that's not something to take
lightly. No, definitely not. Especially, I mean,
you've got things like... like Ray's syndrome
linked to aspirin, right? Oh yeah, that's scary,
especially for kids. And that's mentioned in
the acetaminophen and aspirin reports, right?
So it's like a well -known thing, and then you've
got, you know, diclofenac being like one of the
stronger NSAIDs out there. Yeah, it's up there
in terms of potency, according to the diclofenac
source anyway. So it's clear that there was a
need for something, something that could tackle
the pain and inflammation. Right. But do it without...
you know, messing with your stomach so much.
Yeah, like a better safety profile. Exactly,
and that's kind of where these selective COX2
inhibitors enter the picture. Yeah. It's pretty
fascinating, actually. So how does that work?
So basically, you've got these two enzymes in
the body, COX1 and Keox2. OK. And this comes
up in the ibuprofen, the declofenac, and the
naproxen sources. Gotcha. So Keox1, that's kind
of like the good guy, protects your stomach lining,
helps with blood clotting. OK. And Keox2, well,
that one's more involved in inflammation and
the pain signals. Interesting. So the idea was,
if you could develop a drug that like zeroed
in on COX -2, you could get the pain relief,
fight the inflammation, but without hitting COX
-1 so hard. So less stomach upset. Right. Exactly.
At least that was the theory. That makes a lot
of sense. And that's kind of where coxib slots
in, right? Yeah. So our stuff doesn't say exactly
when it was invented, the eureka moment, but
it's clearly part of this bigger trend in in
NSAID research, like, you know, trying to find
that sweet spot between effectiveness and making
sure it's safe for people. It's like a constant
evolution, right? Yeah, totally. And we see that
even with, you know, like ibuprofen, the source
mentions that it was developed as a better alternative
to aspirin, specifically for being easier on
the stomach. Yeah, and then the proxen info,
it mentions that the company that developed it,
Syntex, they were actually focused on steroids
first. Oh, that's interesting. And then they
moved into NSA. So it's like this whole progression
of trying to find the best way to manage pain
and inflammation. Yeah, exactly. So you can see
how Celecoxib kind of builds on all that. It's
like the next step in this whole journey. It's
fascinating how each drug kind of informs the
next one. Yeah, it's a continuous learning process,
right? Building on what's come before and trying
to improve it. So with Celecoxib being this COX2
selective inhibitor, How was it actually used
in medicine? Like, what's it prescribed for?
Yeah, that's a good question. And honestly, our
sources don't give us a specific list of approved
uses for cellycoxium. But we can kind of make
some educated guesses based on what other NSAIDs
are used for. Right, because it falls under that
umbrella. Exactly. So for instance, diclofenac
that's used for all sorts of things like osteoarthritis,
rheumatoid arthritis, gout, tendonitis, bursitis,
pain after surgery, headaches, even menstrual
cramps. Wow, that's a lot. of different conditions.
Yeah it's got a pretty wide range of applications
and naproxen is similar. Okay. It's used for
ankylosing spondylitis, juvenile idiopathic arthritis,
you know a lot of the same things as diclofenac.
Gotcha and what about ibuprofen? Ibuprofen is
more for like general pain and fever, but it's
also approved for rheumatoid arthritis and osteoarthritis.
So basically we can assume that Celecoxib would
probably be used for for similar types of conditions,
right? Yeah, pretty much anything where pain
and inflammation are the main problems. And the
idea is that with its Keo X2 selectivity, it'll
be, you know, gentler on the stomach compared
to some of those older... Exactly. That's the
big selling point, right? Less of those nasty
GI side effects. Which are no joke. I mean, both
the ibuprofen and the clopinac reports really
emphasize that. Yeah. And the detaclofenac, when
it even says the GI risk, is significant. It's
a real concern. So that's something to keep in
mind. And it's interesting because... the ibuprofen
source points out that while ibuprofen itself
is comparable in how well it works to other NSAIDs,
they can have different safety profiles. Right,
especially when it comes to those GI and cardiovascular
risks. Exactly, and the naproxen report shows
that it also has its own set of GI risks. Yeah,
so it seems like each NSAID kind of has its own...
its own quirks in terms of safety. So even though
we don't have a specific list for silicoxib,
we can kind of put it in this context, right,
of managing pain and inflammation. Yeah, for
sure. But with that added focus on trying to
minimize the stomach issues. Exactly. It's all
about finding that balance, right, effectiveness
and safety. Okay, so let's move on to how Celecoxib
is actually made, like the manufacturing process.
Right, into the factory. Yeah, about that, our
sources don't actually give us any specifics
on that. Oh, really? Yeah, it's kind of a black
box in this case. Huh, so we don't know the secret
recipe. Not exactly, but we do have a lot of
info on how other drugs are made, like acetaminophen,
aspirin, ibuprofen, and naproxen. Okay. So maybe
looking at those can give us some clues, right,
some general ideas. Yeah, I mean, it's got to
be somewhat similar, right? It's all chemistry
at the end of the day. Right. So for example,
acetaminophen, there are actually a couple of
ways to make it. Oh, interesting. Yeah, there's
an older method that uses nitrophenol. And then
there's this more modern selenese process that
uses hydroxyacetaminophen. OK, that's pretty
cool how they find new and better ways to do
things. Exactly. And then you have aspirin, which
is... is actually a pretty straightforward process.
It's just esterifying salicylic acid. OK. And
then with ibuprofen, there's the original boost
process. And then there's this more efficient
modern BHC process. And then you've got naproxen,
which involves all these complex asymmetric synthesis
methods. Wow. Sounds complicated. Yeah, but it's
it's necessary to get the drug in its in its
most effective form So so even though the processes
are different there's there's definitely a common
thread like they all involve You know these precise
chemical reactions very careful purification
steps Absolutely, and and one thing that's highlighted
in all our sources for Diclofenac, ibuprofen,
naproxen, they'll talk about the importance of
quality control. Oh, yeah, that's got to be huge.
You know, making sure everything is up to standard.
Exactly. They all mention adhering to these pharmacopoeial
standards like the USP, the United States Pharmacopeia,
and the European Pharmacopeia. So those set the
bar for like purity and strength and all that.
Exactly. So while we don't know exactly what
goes into making celicoxib, we can be pretty
sure that it involves some pretty intricate chemistry.
Yeah. and a ton of testing at every stage. Right,
to make sure it's safe and effective. OK, so
let's shift gears a bit and talk about the regulatory
pathway for sulcoxib. OK, so how it gets approved.
Yeah, all the hoops you got to jump to. Right,
all the paperwork. Yeah, so again, our sources
don't give us the specifics for sulcoxib. Really?
So we don't know how it like. Navigated the FDA
or anything? No, not exactly, but we do have
some insights into the general process like how
things work in the US and Europe. Okay. From
those reports on acetaminophen, diclofenac, ibuprofen,
mesbroxen. Right, so we can kind of... extrapolate
from that. Exactly. And one thing that's really
emphasized is the importance of clinical trials.
Oh, yeah. Gotta make sure it actually works and
doesn't cause any crazy side effects. Exactly.
And this is mentioned in the acetaminophen, ibuprofen,
and naproxen sources. So it's like a universal
requirement. You gotta prove it's safe and effective.
Absolutely. And another interesting thing is
the difference between over -the -counter drugs
and prescription drugs. Oh, right. Like how some
things you can just buy off the shelf. and others,
you need a doctor's note. Exactly. And both the
acetaminophen and ibuprofen reports touch on
how that whole process works. And then there's
this increasing focus on safety warnings and
potential risks, especially with NSAIDs. Yeah,
that makes sense, especially with all this stuff
about cardiovascular and GI issues. Yeah, and
the Diclofenac, ibuprofen, and naproxen reports
all mention that. So it's like they're under
a microscope. You've got to make sure they're
not. causing more harm than good. So even though
we don't know exactly how silicoxib went through
the process, we know it would have been rigorous.
Right, they wouldn't just like wave it through.
No, there would have been a ton of testing, a
ton of scrutiny, especially with all the concerns
surrounding NSAIDs. Makes you appreciate all
the work that goes into getting a drug approved.
Yeah, for sure. And then of course, there's the
whole question of... controversies and legal
issues. Oh, right, like lawsuits and all that.
Yeah, now our sources don't mention any specific
controversies with coxib itself. OK. But they
do cover a lot of the issues that have come up
with other pain relievers and NSAIDs. So like
what kind of stuff? Well, for example, there's
the whole thing with aspirin and Ray's syndrome.
Oh, right. That was a big deal, right? Yeah,
and that's discussed in the aspirin and acetaminophen
sources. That led to some big changes, right?
Like how aspirin is labeled and who it's given
to. Exactly. Especially for kids, there were
a lot of concerns. Makes sense. You don't want
to be giving something to kids if it could cause,
you know, serious problems. And then, of course,
there are the ongoing concerns about cardiovascular
risks with some NSAIDs. Oh, yeah. That's a big
one these days. And the Diclofenac source is
really informative on this. OK, what does it
say? Well, it mentions that studies have shown
an increased risk of major adverse cardiovascular
events. Wow. That's serious stuff. Yeah. And
they say that this risk is comparable to that
of coxibs. And coxibs, that's the class of drugs
that includes salicoxib, right? Exactly. So it's
definitely relevant. Yeah. That raises some red
flags, for sure. And the ibuprofen and naproxen
reports also mention these cardiovascular concerns.
OK. Especially with higher doses of ibuprofen.
Hmm. So it's not just a coxib thing. Right. And
this has actually led to stronger warnings from
the FDA and the EMA. Wow. So they're really taking
it seriously. Yeah. And they even mentioned this
trial called the Precision Trial, which directly
compared sulacoxib, ibuprofen, and naproxen in
terms of cardiovascular safety. Interesting.
And what were the results? Well, that's where
it gets a bit tricky. The interpretation of the
findings is still being debated. Hmm. So no clear
answers there. Not yet. But it shows you that
this is an active area of research. Yeah. They're
still trying to figure it all out. And then you
have things like liver toxicity, which is a big
concern with acetaminophen. Right. The acetaminophen
report goes into that in detail. Yeah. And declofenac
can also cause liver problems, although it's
pretty rare. So even though we don't have any
specific scandals or anything for Celecoxib,
We can see from these other drugs that... that
there are definitely potential risks to be aware
of. Yeah, it's like a cautionary tale, you know?
Got to be careful with these medications. And
the ibuprofen source actually brings up this
big legal case, the Vioxx litigation. Oh, yeah,
I've heard of that. Wasn't that a coxib as well?
It was, yeah. And it really highlights how these
safety concerns can lead to huge legal battles.
And I bet that had a big impact on how they communicate
the risks of NSAIDs now. Oh, absolutely. So it's
not a stretch to imagine. Celecoxib would have
been under similar scrutiny. Yeah, especially
since it's both an NSAI and a Cabos -2 inhibitor.
All right, so the potential for controversy and
legal issues is definitely there. Makes sense,
you know? They've got to make sure it's as safe
as possible. OK, so let's dive into the economic
side of things, the market impact of Selecoxib.
OK, so like sales and all that? Yeah, how much
money it makes, how it affects the market, all
that good stuff. And like the business side of
things. Exactly. But our sources don't actually
give us specific economic data. for siliconsib.
Oh, OK. So we're flying blind on the numbers.
Kind of. But we do have a lot of information
on the pharmaceutical market in general. OK.
So we can maybe make some educated guesses. Yeah.
For example, the acetaminophen, ibuprofen, and
naproxen reports all talk about the competition
between Brand name drugs right like like Tylenol
versus the generic stuff exactly and and how
that competition usually leads to To lower prices
once the patent on the original drug expires
Yeah, cuz then everyone can like make their own
version right and then the diclofenac and the
proxen sources actually give us some numbers
on the the global market size for Pain relievers
and NSAids. Oh interesting. So like how big are
we talking? Well, the the diclofenac market is
estimated to be billions of dollars annually
Wow, that's a lot of pills. Yeah, it's a huge
market. And the reports on acetaminophen, ibuprofen,
and naproxen also show that making a drug available
over the counter can really boost its sales.
Oh, yeah, because then anyone can buy it. You
don't need a prescription. Exactly. And it's
interesting because the acetaminophen report
mentions how limiting pack sizes in the UK actually
led to a decrease in liver transplants due to
overdose. Really? So it actually had a positive
impact. Yeah. And probably saved the health care
system some money too. So regulation can have
a real economic impact. Absolutely. And then
the ibuprofen source talks about the Vioxx litigation.
Right. The lawsuit we talked about earlier. And
how that really shows how legal issues can shake
things up in the market. Yeah. It can make or
break a drug. So even though we don't have hard
numbers for celicoxib, we can kind of assume
that it follows similar trends, right? Yeah,
especially since it was a brand -name prescription
drug. Exactly. So it probably faced generic competition
once the patent ran out. Right, which would have
driven the price down. And being a prescription
drug, its market reach would have been limited
by how many doctors were prescribing it. Yeah,
it makes sense. It's not like you can just pick
it up at the grocery store. So it's a different
ball game than those over -the -counter drugs.
Definitely. And I'm sure all those economic factors,
like competition and regulation, played a role
in Silicoxib's story. Yeah, for sure. It's all
connected. All right, so for our final stop on
this deep dive, let's talk about the cultural
and societal impact. of celicoxib. Okay, so like
how it's influenced how we think about pain or
how we deal with it. Exactly, like has it changed
the way we live our lives? And honestly, our
sources don't really give us specifics on that
for celicoxib. Oh okay, so we don't know if it's
like sparked any cultural movements or anything.
Not exactly, but we do see how other pain relievers
have made their mark on society. Okay, like what?
Well, the acetaminophen report talks about how
Tylenol and Panadol became household names. Oh
yeah, everyone knows those. And how they were
seen as the safer options after all the race
syndrome worries with aspirin. Right, so that
really shaped people's perceptions. Absolutely,
and the aspirin source actually talks about how
aspirin was like a cultural icon. Really? Yeah.
It was mass marketed early on. It was even used
by NASA. Wow. So it's been around the block.
And the acetaminophen report also mentions the
Tylenol crisis. Oh, yeah. That was scary, people
tampering with the bottles. And that actually
led to a huge change, the development of tamper
-evident packaging. Wow. So it had a lasting
impact on how we package things. Yeah. And both
Acetaminophen and aspirin sources talk about
the role of public health warnings and media
coverage and shaping how people view drugs. Makes
sense. People pay attention to that kind of stuff.
So even though we don't have specific examples
for celicoxib, it's it's safe to assume that
it's had some influence, right? Yeah, especially
since it's a widely prescribed pain reliever.
Exactly. It's probably shaped conversations between
doctors and patients. Right, and been part of
the whole discussion about the pros and cons
of using drugs to manage pain. So it's part of
that bigger picture, even if we don't have all
the details. Yeah, it fits into that whole cultural
understanding of pain and how we deal with it.
So to wrap up our deep dive here, even though
we didn't have a ton of information specifically
on psilococci, we were able to kind of piece
together a pretty good picture by looking at
all those other drugs, aspirin, ibuprofen, naproxen.
declofenac, all that. It was like a puzzle, you
know, putting all the pieces together. Exactly.
And we've seen how it likely fits into the history
of Keo X2 inhibitors. Right, that whole lineage.
And what is probably used for the whole manufacturing
and regulatory process, the potential risks,
the economic factors, even the cultural impact.
Yeah, it's amazing how much you can learn about
one drug by looking at all the others around
it. And I think that's a key takeaway for you
guys listening. Even when you don't have all
the specifics, understanding the bigger context
can be really valuable. Absolutely. It helps
you see the whole picture. And it really makes
you think about all the work that goes into every
single medication. Yeah, all the research, the
testing, the regulations, it's a long road. And
then there's that question of balancing effectiveness
with safety. Right, got to make sure it actually
helps people without causing any undue harm.
And that's an ongoing challenge, right? Yeah,
it's a constant balancing act. So there you have
it, our deep dive into the world of Cellcoxib.
Yeah, hopefully you guys found it informative.
And if you have any other medications you're
curious about, just let us know. Yeah. We're
always up for a challenge. Every drug has its
own story, and we're happy to help you uncover
them. So keep those questions coming. Thanks
for joining us. And we'll see you next time for
another deep dive into the world of pharmaceuticals.
All right. Take care, everyone.